BioSpace News Archive

ReadySet Surgical today announced the launch of RS Capture, enhancing the Company’s cloud-based, end-to-end platform to optimize hospital surgical supply chain management

NeutriSci International Inc. (“NeutriSci” or the “Company”) (TSX-V:NU)(OTCQB:NRXCF)(FRANKFURT:1N9), an innovative technology company developing products for the nutraceutical industry, in conjunction with its manufacturing partner, Cryopharm, is pleased to announce the latest business developments.

Mopec —a leading provider of high-quality pathology, anatomy, mortuary, and necropsy equipment and products—today announced the appointment of Richard Leach as Government Sales and Contracts Manager. Leach

IMMUNOPRECISE ANTIBODIES LTD. (the “Company” or “IPA”) (TSXV: IPA) (OTCQB: IPATF) (FSE:TQB2), a leader in full-service, therapeutic antibody discovery and development, today announced that Dr. Jennifer Bath, CEO of IPA, is scheduled to appear today as a guest on Bloomberg Technology with host Emily Chang at approximately 5:10 p.m. ET.

The American Academy of Orthopaedic Surgeons (AAOS) announced a plan to launch a Fracture & Trauma Registry (FTR) and begin collecting data on five of the more common fractures in the United States.

OnLume Surgical, a medical device company developing novel imaging systems for use during surgery, was recognized as one of the ten (10) finalists for the 2020 Wisconsin Innovation Awards.

Stryker (NYSE:SYK) announced that it will host a conference call on Thursday, October 29, 2020 at 4:30 p.m., Eastern Time, to discuss the Company’s operating results for the quarter ended September 30, 2020 and provide an operational update. Final operating results for the quarter ended September 30, 2020 will be released at 4:05 p.m. that day. To participate in the conference call dial (877) 702-4565 (domestic) or (647) 689-5532 (intern

Baylor College of Medicine and The Menninger Clinic jointly announce the hiring of Robert J. Boland , M.D., as vice chairman of the Menninger Department of Psychiatry and Behavioral Sciences at Baylor College of Medicine and chief of staff at The Menninger Clinic. Boland joins the organizations on January 4, 2021 , after tran

Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage genetic medicines company committed to delivering life-changing treatments for people battling devastating diseases, announced today that Paul Bolno, MD, MBA, President and Chief Executive Officer, is scheduled to present at the Chardan Virtual 4th Annual Genetic Medicines Conference on Tuesday, October 6, 2020 at 4:45 p.m. ET. A live webcast of the presentation will be available on t

DTx Pharma, Inc. (DTx), a privately-held biotechnology company creating novel RNA-based therapeutics to treat the genetic drivers of disease, announced today that Arthur T. Suckow , Ph.D., CEO of DTx Pharma, will be presenting a company overview and will participate in 1x1 meetings at the Chardan Virtual 4 th Annual Genetic Medicin